Search Results 941-950 of 17634 for Prednisone

  1. A Study to Evaluate Docetaxel With or Without Bintrafusp Alfa to Treat Patients with Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Taking oral prednisone of ≥ 10 mg daily or equivalent. Known clinically significant liver disease, including active viral, alcoholic, or other hepatitis ...

  2. A Study to Evaluate Enfortumab Vedotin to Treat Metastatic Squamous Cell Carcinoma of the Penis - Mayo Clinic

    If needed, steroid dose is stable and ≤ 20 mg/day of prednisone or equivalent for ≥ 2 weeks prior to registration;; Baseline imaging shows no evidence of ...

  3. Anesthesiology and Perioperative Medicine - Overview - Mayo Clinic

    Obstetric analgesia and anesthesia; Preoperative medical evaluations; Perioperative pain management; Point-of-care ultrasound; Spinal cord stimulation; Spinal- ...

  4. Research: It's all about patients - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to ...

  5. A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma - Mayo Clinic

    ... prednisone or equivalent), within 28 days of first dose of study drug on Cycle 1 Day 1. 14. Patient has history of drug-related anaphylactic reactions to ...

  6. Subconjunctival hemorrhage (broken blood vessel in eye) - Diagnosis & treatment - Mayo Clinic

    If you have recurrent subconjunctival hemorrhages, your doctor may also: Ask you questions about your general health and symptoms; Conduct an eye examination ...

  7. ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension - Mayo Clinic

    Use of prednisone ≥10mg/day within 3 months prior to screening, or other significant immunosuppression as deemed by the investigator. 24. Estimated ...

  8. A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer - Mayo Clinic

    Subjects with a condition requiring systemic treatment with either corticosteroids (>10 mg daily prednisone equivalents) or other immunosuppressive medications ...

  9. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Palliative steroids must be at a dose not higher than 20 mg/day of prednisone or equivalent corticosteroid at the time of registration. ... Patients must not ...

  10. Sorafenib (oral route) - Side effects & dosage - Mayo Clinic

    Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, ...